Scientific publications
2001
Nonsense-mediated
mRNA decay: insights into mechanism from the cellular abundance of
human Upf1, Upf2, Upf3, and Upf3X proteins (Review)
L.E. Maquat and G. Serin
Cold Spring Harb Symp Quant Biol. 2001, 66: 313-20
Modulation
of apoptosis by procaspase-2 short isoform : selective inhibition of
chromatin condensation, apoptotic body formation and
phosphatidylserine externalisation
N. Droin, C. Rebe, F. Bichat,
A. Hamman, R. Bertrand and E. Solary
Oncogene, 2001 Jan 11, 20(2):
260-9
Identification
and characterization of human orthologues to Saccharomyces cerevisiae
Upf2 protein and Upf3 protein (Caenorhabditis elegans SMG-4)
G. Serin,
A. Gersappe, J.D. Black, R. Aronoff and L.E. Maquat
Mol Cell Biol, 2001 Jan, 21(1): 209-23
Involvement
of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells
N. Droin, F. Bichat, C. Rebe, A. Wotawa, O. Sordet, A. Hammann, R. Bertrand and E. Solary
Blood, 2001 Mar 15, 97(6): 1835-44
Evidence
for a pioneer round of mRNA translation: mRNAs subject to
nonsense-mediated decay in mammalian cells are bound by CBP80 and
CBP20
Y. Ishigaki,
X. Li, G. Serin and L.E. Maquat
Cell, 2001 Sep 7, 106(5): 607-17
Constitutive
NF-kappaB activity influences basal apoptosis and radiosensitivity of
head-and-neck carcinoma cell lines
C. Didelot,
M. Barberi-Heyob, A. Bianchi, P. Becuwe, J.F. Mirjolet, M. Dauca and J.L. Merlin
Int J Radiat Oncol Biol Phys, 2001 Dec 1, 51(5): 1354-60
2000
Effect
of cyclosporin at various concentrations on dexamethasone
intracellular uptake in multidrug resistant cells
J.F.
Maillefert, O. Duchamp, E. Solary, P. Genne and C. Tavernier
Ann
Rheum Dis., 2000 Feb, 59(2): 146-8
P27KiP1
over expression inhibits the growth and doxorubicn sensitivity of
HT29 human colon cancer cells in vivo
M.
Dimanche-Boitrel, O. Micheau, D. France, A. Hammann, O.
Duchamp, P. Genne and E. Solary
Anticancer Research, 2000 Mar-Apr, 20(2A): 849-52
Bcl-2/Bax
protein ratio predicts 5-fluorouracil sensitivity independently of
p53 status
J.F. Mirjolet, M. Barberi-Heyob, C. Didelot and J.P. Peyrat,
J. Abecassis, R. Millon and J.L. Merlin
Br J Cancer., 2000 Nov,
83(10): 1380-6
Phase
I study of cinchonine, a multidrug resistance reversing agent,
combined with the CHVP regimen in relapsed and refractory
lymphoproliferative syndromes
E. Solary, L. Mannone, D. Moreau,
D. Caillot, R-O. Casasnovas, H. Guy, M. Grandjean, J-E. Wolf, F.
André, P. Fenaux, P. Canal, B. Chauffert, A. Wotawa, M.
Bayssas and P. Genne
Leukemia, 2000 Dec, 14(12): 2085-94
Preclinical
evaluation of aromatase inhibitors antitumor activity (Review in French)
P.
Auvray, F. Bichat and P. Genne
Bull Cancer, 2000 Dec, 87 Spec
No: 7-22
Enhanced
targeting specificity to tumor cells by simultaneous recognition of
two antigens
M. Hillairet de Boisferon, O. Raguin, M.
Dussaillant, W. Rostène, J. Barbet and A. Gruaz-Guyon
Bioconjug. Chem., 2000, 11(4): 452-460
1999
MDR1
and thymidylate synthase gene expressions in advanced breast cancer:
relationships to P53 mutations, response to primary chemotherapy and
survival
S. Lizard-Nacol, P. Genne, B. Coudert, J.M. Riedinger,
M. Arnal, C. Sancy, P. Brunet-Lecomte and P. Fargeot
Anticancer
Research, 1999 Jul-Aug, 19(4C): 3575-81
|
Home
Back
Top